U.S. House · 118th Congress · H.R. 7535
Prescription Drug Supply Chain Pricing Transparency Act
To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Yadira CaraveoD-CO-8
- Introduced
- March 5, 2024, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Tracey MannR-KS-1